CE approval for Zebra’s Deep Learning Imaging Engine
8 June, 2017
Zebra Medical provides automated analysis of millions of real-time and retrospective imaging studies, for early identification of diseases
Zebra Medical Vision from Shfayim, Israel, has been granted the CE approval for its Deep Learning Analytics Engine, for use in Europe, Australia and New Zealand. The company’s Analytics Engine provides automated analysis of imaging data, helping radiologists provide faster, more accurate and comprehensive reports. The Engine can be integrated into PACS, RIS, Reporting and EMR systems.
“These recent regulatory approvals allow us to continue driving adoption of our Analytics Engine globally, where we see significant interest in countries that have a problematic ratio of radiologists per capita. Providing tools that assist them in delivering better care is critical and is the driving force behind our mission,” says Elad Benjamin, Co-Founder and CEO at Zebra-Med. “We have already begun working with luminary university hospitals in Europe, and will continue to expand our footprint across the region.”
AI Revolutionize Radiology
Artificial Intelligence in healthcare has been gaining significant support and adoption over the past 12 months. In a recent Research and Markets market report, it was estimated that Artificial Intelligence in healthcare will witness a CAGR of 62.2% between 2016-2022. The Zebra-Med Engine currently analyzes CT data for signs of Fatty Liver, Excess coronary calcium, Emphysema, Low bone density and Vertebral compression fractures.
“Machine Learning will change the way Radiology is practiced in the coming years,” says Prof. Gabriel Krestin, Chairman of the Department of Radiology and Nuclear Medicine at Erasmus MC, University Medical Centre Rotterdam, the Netherlands. “I believe it will make radiologists more productive, and I also believe that new use cases and value propositions will emerge as the technology is implemented widely. It is a very exciting time for radiology.”
Headquartered in Kibbutz Shefayim, Israel, the company was founded in 2014 by co-founders Eyal Toledano, Eyal Gura, and Elad Benjamin, and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd and Dolby Ventures. Zebra’s technology provides automated analysis of millions of real-time and retrospective imaging studies. This allows early identification of disease, and implementation of decision support tools for population health and risk management. In the coming months Zebra-Medical plans to release more than a dozen new algorithms that detect life threatening diseases.